Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads, Mastodon, and Bluesky. You can reach Brittany on Signal at btrang.01.

SAN FRANCISCO — AI giant Anthropic has already become a dominant player in technology and a household name for everyday users of artificial intelligence. Can it make drugs too?

On Tuesday, the company announced it is going to try. Though it’s unclear whether Anthropic intends to bring drug candidates to commercialization, multiple executives emphasized how important it is for Anthropic to get hands-on experience trying to use its own products to solve real scientific problems. 

Advertisement

Eric Kauderer-Abrams, the company’s head of life sciences, said Anthropic has been asking itself what it should be doing besides training models and building products. During an event here to launch the company’s newest application, Claude Science, he said Anthropic had come up with one answer.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Individual plans Group plans View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe